Improve Medical Instruments Co., Ltd. (SHE:300030)
China · Delayed Price · Currency is CNY 5.97
-0.14 (-2.29%)
Oct 28, 2026, 1:55 PM CST
SHE:300030 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 115.1 | 160.32 | 247.95 | 214.71 | 221.05 | 345.74 |
Short-Term Investments | - | - | 1.01 | - | - | - |
Trading Asset Securities | 22 | - | - | 23 | 3 | - |
Cash & Short-Term Investments | 137.1 | 160.32 | 248.96 | 237.71 | 224.05 | 345.74 |
Cash Growth | -14.65% | -35.60% | 4.73% | 6.10% | -35.20% | 27.29% |
Accounts Receivable | 113.83 | 163.34 | 205.95 | 185.67 | 228.24 | 231.72 |
Other Receivables | 3.72 | 3.6 | 4.98 | 86.89 | 83.82 | 76.59 |
Receivables | 117.54 | 166.94 | 210.93 | 272.56 | 312.06 | 308.31 |
Inventory | 76.12 | 81.15 | 102.88 | 132.47 | 139.3 | 151.66 |
Prepaid Expenses | - | 1.19 | 0.9 | 0.73 | - | 4.62 |
Other Current Assets | 15.64 | 13.74 | 25.43 | 20.96 | 42.84 | 33.61 |
Total Current Assets | 346.42 | 423.34 | 589.1 | 664.43 | 718.24 | 843.94 |
Property, Plant & Equipment | 363.92 | 357.61 | 377.05 | 370.62 | 407.12 | 408.54 |
Long-Term Investments | 103.06 | 165.49 | 183 | 252.42 | 264.14 | 312.67 |
Goodwill | - | - | 7.8 | 19.67 | 22.61 | 76.23 |
Other Intangible Assets | 30.85 | 33.71 | 38.64 | 44.29 | 76.22 | 119.59 |
Long-Term Accounts Receivable | - | - | 0.07 | 25.64 | 8.72 | 8.54 |
Long-Term Deferred Tax Assets | 31.93 | 35.85 | 38.68 | 39.42 | 52.69 | 29.44 |
Long-Term Deferred Charges | 4.3 | 5.18 | 5.9 | 2.69 | 4.81 | 8.95 |
Other Long-Term Assets | 48.88 | 5.73 | 3.9 | 6.78 | 3.64 | 17.15 |
Total Assets | 929.36 | 1,027 | 1,244 | 1,426 | 1,558 | 1,825 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 74.35 | 70.58 | 81.37 | 89.94 | 118.65 | 82.47 |
Accrued Expenses | 21.84 | 45.54 | 51.89 | 41.77 | 38.77 | 39.72 |
Short-Term Debt | 33.37 | 119.97 | 282.02 | 353.79 | 382.3 | 247.3 |
Current Portion of Long-Term Debt | - | 8.72 | 10.8 | 29.53 | 3.04 | 218.13 |
Current Portion of Leases | - | 0.34 | 3.35 | 5.6 | 8.89 | 13.2 |
Current Income Taxes Payable | 6.23 | 0.38 | 0.44 | 0.56 | 0.87 | 0.62 |
Current Unearned Revenue | 48.69 | 64.31 | 75.28 | 71.49 | 75.22 | 61.42 |
Other Current Liabilities | 32.32 | 8.04 | 6.93 | 10.69 | 10.73 | 14.78 |
Total Current Liabilities | 216.81 | 317.87 | 512.07 | 603.37 | 638.46 | 677.64 |
Long-Term Debt | 17.45 | 24.03 | 51.72 | 6 | 25.5 | 28.5 |
Long-Term Leases | 0.46 | 0.66 | 2.32 | 5.5 | 6.56 | 17.7 |
Long-Term Unearned Revenue | 20.42 | 23.43 | 28.71 | 37.82 | 59.95 | 64.45 |
Long-Term Deferred Tax Liabilities | 0.33 | 1.85 | 1.48 | 6.11 | 4.4 | 6.33 |
Other Long-Term Liabilities | 5.46 | 3.98 | 3.98 | 4.83 | 2.7 | - |
Total Liabilities | 260.93 | 371.82 | 600.28 | 663.63 | 737.57 | 794.63 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 309.19 | 309.19 | 309.19 | 309.19 | 309.19 | 309.19 |
Additional Paid-In Capital | 399.05 | 399.05 | 399.05 | 399.05 | 399.05 | 399.05 |
Retained Earnings | -64.24 | -83.11 | -97.64 | 20.26 | 83.47 | 294.28 |
Comprehensive Income & Other | -4.71 | -4.79 | -3.87 | -5.42 | -7.36 | -2.33 |
Total Common Equity | 639.29 | 620.34 | 606.73 | 723.08 | 784.35 | 1,000 |
Minority Interest | 29.14 | 34.76 | 37.13 | 39.25 | 36.26 | 30.24 |
Shareholders' Equity | 668.43 | 655.1 | 643.86 | 762.33 | 820.61 | 1,030 |
Total Liabilities & Equity | 929.36 | 1,027 | 1,244 | 1,426 | 1,558 | 1,825 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 51.28 | 153.73 | 350.2 | 400.42 | 426.29 | 524.83 |
Net Cash (Debt) | 85.82 | 6.59 | -101.24 | -162.71 | -202.25 | -179.09 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 0.29 | 0.02 | -0.33 | -0.51 | -0.65 | -0.58 |
Filing Date Shares Outstanding | 327.06 | 309.19 | 309.19 | 309.19 | 309.19 | 309.19 |
Total Common Shares Outstanding | 327.06 | 309.19 | 309.19 | 309.19 | 309.19 | 309.19 |
Working Capital | 129.6 | 105.47 | 77.03 | 61.06 | 79.78 | 166.3 |
Book Value Per Share | 1.95 | 2.01 | 1.96 | 2.34 | 2.54 | 3.23 |
Tangible Book Value | 608.43 | 586.62 | 560.29 | 659.13 | 685.52 | 804.37 |
Tangible Book Value Per Share | 1.86 | 1.90 | 1.81 | 2.13 | 2.22 | 2.60 |
Buildings | - | 342.49 | 258.61 | 258.36 | 285.31 | 265.73 |
Machinery | - | 256.07 | 266.12 | 314.35 | 311.92 | 278.11 |
Construction In Progress | - | 0.35 | 80.54 | 45.35 | 34.76 | 63.2 |